Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06208241
EARLY_PHASE1
Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety
Sponsor: Amir Oron
View on ClinicalTrials.gov
Summary
This is a pilot study to assess safety and possible efficacy of Allocetra-OTS in end-stage knee osteoarthritis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2023-07-12
Completion Date
2025-12-30
Last Updated
2025-08-05
Healthy Volunteers
No
Conditions
Interventions
DRUG
Allocetra-OTS
Allocetra-OTS is a cell-based therapy consisting of non-HLA-matched allogeneic peripheral blood mononuclear cells, derived from a healthy human donor following a leukapheresis procedure, induced to an apoptotic stable state and suspended in a solution containing DMSO.
Locations (1)
Kaplan Medical Center
Rehovot, Israel